The MELAS syndrome. Review of the literature: The role of the otologist

Clinical Otolaryngology and Allied Sciences

Volumn 29, Issue 1, 2004, Pages 1-4

  Karkos, P D ^a   Waldron, M ^a   Johnson, I J ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; OPIATE; SEDATIVE AGENT;

ACOUSTIC REFLEX; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE EXACERBATION; ELECTROCOCHLEOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; GENETIC DISORDER; HUMAN; IMPLANTATION; MALIGNANT HYPERTHERMIA; MELAS SYNDROME; MITOCHONDRIAL DNA DISORDER; OTOACOUSTIC EMISSION; OTORHINOLARYNGOLOGY; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; REVIEW; SOCIAL SUPPORT; SPEECH AUDIOMETRY; TYMPANOMETRY; VITAMIN SUPPLEMENTATION;

DNA, MITOCHONDRIAL; HEARING LOSS, SENSORINEURAL; HUMANS; MELAS SYNDROME; OTOLARYNGOLOGY; PHYSICIAN'S ROLE;

EID: 1642463323     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2273.2004.00769.x     Document Type: Review

References (35)

1. NANCE W.E. (1980) The genetic analysis of profound prelingual deafness. Birth Defects 16, 263-269
2. NADOL J.B.J. & MERCHANT S.N. (2001) Histopathology and molecular genetics of hearing loss in the human. Int. J. Pediatr. Otorhinolaryngol. 61, 1-15
3. PETIT C. (1996) Genes responsible for human hereditary deafness: symphony of a thousand. Nat. Genet. 14, 385-391
4. PAVLAKIS S.G. (1984) Mitochondrial myopathy, encephalomyopathy, lactic acidosis and stroke-like episodes: a distinctive clinical syndrome. Ann. Neurol. 16, 481-488
5. ROWLAND L.P. (1983) Diverse clinical disorders associated with morphological abnormalities of mitochondria. In Mitochondrial Pathology Muscular Diseases, CERRI C., SCARLATO, G. (eds), pp. 141-158. Pikin Medical Books, Padua, Italy
6. FUKUHARA N., TOKIGUCHI S., SHIRAKAWA K. et al. (1980) Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): disease entity or a syndrome? J. Neurol. Sci. 47, 117-133
7. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes and deafness. Nat. Genet. 1, 368-371
8. SCHWARTZ M. & VISSING J. (2002) Paternal inheritance of mitochondrial disease. N. Engl. J. Med. 347, 576-580
9. KEATS B.J.B. (2002) Genes and syndromic hearing loss. J. Commun. Disord. 35, 355-366
10. GOTO Y., NONAKA I. & HORAI S. (1990) A mutation in the t-RNA (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348, 651-653
11. MAJAMAA K., MOILANEN J.S., UIMONEN S. et al. (1998) Epidemiology of A3243G, the mutation of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes: prevalence of the mutation in an adult population. Am. J. Human Genet. 63, 447-54
12. OSHIMA T., IKEDA K., UEDA N. et al. (1999) Sensorineural hearing loss with a mitochondrial gene point mutation is highly prevalent in Japan. In Association for Research in Otolaryngology, pp. 11. St Petersburgh, Florida
13. DALLOS P. & EVANS B.N. (1995) High frequency motility of outer hair cells and the cochlear amplifier. Science 267, 2006-2009
14. FERNANDEZ T. & HINOGOSA R. (1974) Postnatal development of endocochlear potential and stria vascularis in the cat. Acta Otolaryngol. (Stockh.) 78, 173-186
15. DONOVAN T. (1995) Mitochondrial encephalomyopathy: a rare genetic cause of sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 104, 786-791
16. CHINNERY P.F. & TURNBULL D.M. (1997) Clinical features investigation and management of patients with defects of mitochondrial DNA. J. Neurol. Neurosurg. Psychiatry 63, 559-563
17. HIRANO M. & PAVLAKIS S.G. (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J. Child Neurol. 9, 4-13
18. EDMONDS K.L., KIRSE D., KEARNS D. et al. (2002) The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch. Otolaryngol. Head Neck Surg. 128, 355-362
19. DESSHAUER M., MULLER T., WIESER T. et al. (2001) Hearing impairment is common in various phenotypes of the mitochondrial DNA A3243G mutation. Arch. Neurol. 58, 1885-1888
20. CHINNERY P.F., HOWELL N., LIGHTOWLERS R.N. et al. (1997) Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 120, 1713-1721
21. CHINNERY P.F., ELLIOTT C., GREEN G. et al. (2000) The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123, 82-92
22. SWIFT A.C. & SINGH S.D. (1998) Hearing impairment and the Kearns-Sayne syndrome. J. Laryngol. Otol. 102, 626-627
23. VERNHAM G.A., REID F.M., RUNDLE P.A. et al. (1994) Bilateral sensorineural hearing loss in members of a maternal lineage with a mitochondrial point mutation. Clin. Otolaryngol. 19, 314-319
24. SUE C.M., LIPSETT L.J. & CRIMMINS D.S. (1998) Cochlear origin of hearing loss in MELAS syndrome. Ann. Neurol. 43, 350-359
25. NAVIAUX R.K. (1999) The mitochondrial DNA depletion syndromes. In Atlas of Metabolic Disease, NYHAN W.L. & OZAND, P.T. (eds), pp. 314-320. Chapman & Hall, New York, NY
26. HIRANO M., RICCI E., KOENISBERGER M.R. et al. (1992) MELAS: an original case and clinical criteria for diagnosis. Neuromuscul. Disord. 2, 125-135
27. BINDOFF L.A., JACKSON S. & TURNBULL D.M. (1994) Mitochondrial and lipid storage disorders of muscle. In Diseases of Voluntary Muscle, pp. 717-740. Churchill Livingstone, London
28. WARRICK P.D., WARDROP P. & SIM D.W. (1997) Sensorineural hearing loss in MELAS syndrome. J. Laryngol. Otol. 111, 279-287
29. CHINNERY P.F. & TURNBULL D.M. (1999) Mitochondrial DNA and disease. Lancet 354 (Suppl. I), 1721
30. THOMPSON V.A. & WAHR J.A. (1997) Anesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS) syndrome. Anesth. Analg. 85, 1404-1406
31. CARROLL J.E., ZWILLICH C., WEIL J.V. et al. (1976) Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology 26, 140-146
32. SHAPIRA Y., CEDERBAUM S. & CANCILLA P (1975) Familial poliodystrophy, mitochondrial myopathy and lactate acidemia. Neurology 25, 614-621
33. SKOGLAND R. (1979) Reversible alexia, mitochondrial myopathy and lactate acidemia. Neurology 29, 717-723
34. HILL D., WINTERSGILL S., SCOTT L. et al. (2001) Cochlear implantation in a profoundly deaf patient with MELAS syndrome. J. Neurol. Neurosurg. Psychiatry 71, 281
35. ROSENTHAL E.Z., KILENY P.R., BOERST A. et al. (1999) Successful cochlear implantation in a patient with MELAS syndrome. Am. J. Otol. 20, 187-190